Home LiteratureArticle Details
PMID: 20857339 Published · ppublish English Journal Article Review

Understanding equivalence and noninferiority testing.

Journal of general internal medicine ·Vol. 26 ·No. 2 ·2011-02-00 ·Pages 192-6

Walker E, Nowacki AS

Abstract

Increasingly, the goal of many studies is to determine if new therapies have equivalent or noninferior efficacies to the ones currently in use. These studies are called equivalence/noninferiority studies, and the statistical methods for their analysis require only simple modifications to the traditional hypotheses testing framework. Nevertheless, important and subtle issues arise with the application of such methods. This article describes the concepts and statistical methods involved in testing equivalence/noninferiority. The aim is to enable the clinician to understand and critically assess the growing number of articles utilizing such methods.

MeSH Terms
Comprehension Humans Research Design/standards Sample Size Therapeutic Equivalency
Authors & Affiliations
2 authors, click to expand affiliations / ORCID
Walker Esteban
Department of Quantitative Health Sciences, Cleveland Clinic, 9500 Euclid Avenue/JJN3 - 01, Cleveland, OH 44195, USA. walkere1@ccf.org
Nowacki Amy S
References (13)
13 references, click to expand
  1. Comparison of fondaparinux and enoxaparin in acute coronary syndromes.
    N Engl J Med. 2006 Apr 6;354(14):1464-76 PMID: 16537663
  2. Quality of reporting of noninferiority and equivalence randomized trials.
    JAMA. 2006 Mar 8;295(10):1147-51 PMID: 16522835
  3. A comparison of the two one-sided tests procedure and the power approach for assessing the equivalence of average bioavailability.
    J Pharmacokinet Biopharm. 1987 Dec;15(6):657-80 PMID: 3450848
  4. Good enough: a primer on the analysis and interpretation of noninferiority trials.
    Ann Intern Med. 2006 Jul 4;145(1):62-9 PMID: 16818930
  5. Reporting of noninferiority and equivalence randomized trials: an extension of the CONSORT statement.
    JAMA. 2006 Mar 8;295(10):1152-60 PMID: 16522836
  6. Placebo-controlled trials and active-control trials in the evaluation of new treatments. Part 1: ethical and scientific issues.
    Ann Intern Med. 2000 Sep 19;133(6):455-63 PMID: 10975964
  7. Therapeutic equivalence: fallacies and falsification.
    Stat Med. 2003 Mar 15;22(5):741-62 PMID: 12587103
  8. Lessons from and cautions about noninferiority and equivalence randomized trials.
    JAMA. 2006 Mar 8;295(10):1172-4 PMID: 16522840
  9. Practical issues in equivalence trials.
    Stat Med. 1998 Aug 15-30;17(15-16):1691-701 PMID: 9749440
  10. Abacavir-lamivudine-zidovudine vs indinavir-lamivudine-zidovudine in antiretroviral-naive HIV-infected adults: A randomized equivalence trial.
    JAMA. 2001 Mar 7;285(9):1155-63 PMID: 11231744
  11. Placebo-controlled trials and active-control trials in the evaluation of new treatments. Part 2: practical issues and specific cases.
    Ann Intern Med. 2000 Sep 19;133(6):464-70 PMID: 10975965
  12. The role of intention to treat in analysis of noninferiority studies.
    Clin Trials. 2007;4(3):286-91 PMID: 17715258
  13. Assessing equivalence: an alternative to the use of difference tests for measuring disparities in vaccination coverage.
    Am J Epidemiol. 2002 Dec 1;156(11):1056-61 PMID: 12446263
Article Info
Journal
Journal of general internal medicine
Abbr.
J Gen Intern Med
ISSN
1525-1497
Published
2011-02-00
Epub
2010-00-21
Pages
192-6
Language
English
Region
United States
NLM ID
8605834
PMCID
PMC3019319
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com